{
    "id": "44365077",
    "text": "Stem Cell Theranostics is a privately held biotech company based out of Redwood City, California that provides drug companies with a method to more accurately predict cardiotoxicity and cardiovascular drug efficacy. ==History== Stem Cell Theranostics was one of the first med tech startup to come out of the StartX incubator program. The company uses technology developed at Stanford, to create a \"clinical trial in a dish\" drug screening platform, which reduces the risk of drug development. The company currently works with drug discovery and biotechnology companies to use patient-specific induced pluripotent stem cells for development of novel therapeutics. ==References== ==External links== * Category:Companies based in Redwood City, California Category:Biotechnology companies established in 2011 Category:Technology companies based in the San Francisco Bay Area Category:2011 establishments in California ",
    "title": "Stem Cell Theranostics"
}